Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Repligen reported $0 in Loan Capital for its fiscal quarter ending in June of 2022.

Loan Capital Change
Agilent A:US USD 2.73B 0
Bio Techne TECH:US USD 370M 170M
BioMarin Pharmaceutical BMRN:US USD 1.08B 803K
Bruker BRKR:US USD 1.11B 91.5M
Catalent CTLT:US USD 4.22B 123M
Charles River Laboratories CRL:US USD 2.74B 36.24M
Danaher DHR:US USD 18.26B 825M
Dentsply International XRAY:US USD 1.84B 16M
Exact Sciences EXAS:US USD 2.37B 123.49M
General Electric GE:US USD 20.16B 8.43B
Henry Schein HSIC:US USD 1.02B 19M
Illumina ILMN:US USD 1.49B 0
IQVIA Holdings Inc IQV:US USD 11.83B 762M
NanoString Technologies NSTG:US USD 227M 379K
OraSure Technologies OSUR:US USD 472K 31K
Pacific Biosciences Of California PACB:US USD 896.84M 156K
Patterson Companies PDCO:US USD 451.91M 33.61M
Peregrine Pharmaceuticals PPHM:US USD 142.06M 129K
PerkinElmer PKI:US USD 3.88B 42.36M
Thermo Fisher Scientific TMO:US USD 29.14B 226M
Waters WAT:US USD 1.43B 94.75M
West Pharmaceutical Services WST:US USD 206.1M 600K